.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Mallinckrodt
Boehringer Ingelheim
Cerilliant
Deloitte
Baxter
Cantor Fitzgerald
AstraZeneca
Farmers Insurance
Johnson and Johnson

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088483

« Back to Dashboard
NDA 088483 describes ANTABUSE, which is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs. It is available from three suppliers. Additional details are available on the ANTABUSE profile page.

The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the disulfiram profile page.

Summary for NDA: 088483

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 088483

Suppliers and Packaging for NDA: 088483

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANTABUSE
disulfiram
TABLET;ORAL 088483 ANDA Teva Pharmaceuticals USA, Inc. 0093-5036 0093-5036-01 100 TABLET in 1 BOTTLE (0093-5036-01)
ANTABUSE
disulfiram
TABLET;ORAL 088483 ANDA Teva Women's Health, Inc. 51285-524 51285-524-02 100 TABLET in 1 BOTTLE (51285-524-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Dec 8, 1983TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Cipla
Daiichi Sankyo
US Army
Express Scripts
Mallinckrodt
Farmers Insurance
McKesson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot